Clinical Trial Update: Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 trial updates the efficacy and safety of BCT197 in acute respiratory exacerbations of chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BCT197

Snippet

Sponsor: Mereo BioPharma | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: COMPLETED | Results posted: 2020-11-30